Mankind Pharma and other domestic companies have launched generic versions of the popular diabetes drug Empagliflozin at ...

ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Nitazoxanide Tablets, 500 mg. ANI ...

Ars Pharmaceuticals, Inc. (($SPRY)) has held its Q4 earnings call. Read on for the main highlights of the call. The recent earnings call for ARS ...

This article was originally published on Quiver News, read the full story. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of ...

Thanks to the spending growth cap, the U.K. government in December 2024 announced that companies would need to pay a 22.9% ...

The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...

SaaS solution minimizes manual processes, accelerates batch release cycles and meets regulatory compliance* Pharmaceutical companies face numerous challenges in ensuring product integrity ...

Tonix Pharmaceuticals (TNXP) stock falls as the company misses Street forecasts on Q4 2024 revenue miss ahead of an FDA ...

JELMYTO, the company's existing therapeutic product ... UroGen Pharma is positioned for transformative growth in 2025, driven by the potential approval and launch of UGN-102.

Eton Pharmaceuticals' ET-600 met bioequivalence standards in a study, with an FDA filing planned for April 2025 and a ...

Cycle Pharmaceuticals Limited (Cycle) announced today the launch of VENXXIVA (tiopronin) Delayed-Release Tablets, for the treatment of cystinuria, approved by the US Food and Drug Administration (FDA) ...

ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Nitazoxanide Tablets, 500 mg. ANI's Nitazoxanide Tablets ...